Average Co-Inventor Count = 6.84
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (10 from 3,685 patents)
2. Glenmark Pharmaceuticals S.a. (1 from 65 patents)
11 patents:
1. 11008306 - Quinazolines as potassium ion channel inhibitors
2. 10676460 - Quinazolines as potassium ion channel inhibitors
3. 10227340 - Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
4. 10214511 - Quinazolines as potassium ion channel inhibitors
5. 9862715 - Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
6. 9458114 - Quinazolines as potassium ion channel inhibitors
7. 9242975 - Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
8. 9242976 - Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
9. 9006257 - Bicyclic compounds as mPGES-1 inhibitors
10. 8987311 - Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
11. 8575184 - Quinazolines as potassium ion channel inhibitors